rs10974944

badMag 6.5

This is a intron variant variant in the JAK2 gene.

Key Literature Trait Associations

Myeloproliferative Neoplasm Susceptibility

The G allele at rs10974944 tags the JAK2 46/1 haplotype, which preferentially acquires the somatic JAK2 V617F mutation and confers a ~3-fold increased risk of myeloproliferative neoplasms. In a GWAS of 2,636 MPN cases and 14,146 controls, this haplotype was strongly associated with polycythemia vera, essential thrombocythemia, and primary myelofibrosis (Jones et al., 2009).

Sukarawan W et al. WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors. The American Journal of Pathology 176(1):461-471 (2010)
Allele G
OR 3.10
p 3.0e-13
Large GWAS
Allele G
OR
p
Candidate gene study
European
Allele G
OR
p 1.0e-4
N 299
Candidate gene study
European (Romanian)
Allele G
OR 3.40
p 1.0e-4
Candidate gene study
South American (Brazilian Amazon)

Research that mentions this SNP (1)

The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms
AssociationN=299Adrian P. Trifa et al.(2010)· Annals of Hematology

This case-control study of 149 myeloproliferative neoplasm (MPN) patients and 150 controls demonstrates that the G allele of JAK2 rs10974944 (part of the JAK2 46/1 haplotype) is strongly associated with JAK2 V617F-positive MPN (p<0.0001, OR=5.2 for GG/CG vs CC). The association is specific to V617F-positive cases and correlates with higher mutant allele burden (>50% vs <50%, p=0.0006, OR=6.1).

Traits studied:Essential thrombocythemiaMyeloproliferative neoplasmsPolycythemia veraPrimary myelofibrosis

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…